Browse wiki

From OpenCongress Wiki

Jump to: navigation, search
U.S. prescription drug legislation
Bill of vote U.S. prescription drug legislation +
Chamber 111th United States Congress + , U.S. Senate +
Congress number 110th +
Modification date
Roll call number 617 + , 151 +
Scorecard vote U.S. Chamber of Commerce 2007 House Scorecard + , U.S. Chamber of Commerce 2007 Senate Scorecard +
Session number 1 +
U.S. Chamber of Commerce 2007 House Scorecard description With the full support of the Chamber, the With the full support of the Chamber, the House passed H.R. 2900, the Food and Drug Amendments Act of 2007, 403-16. This broadly supported, bipartisan legislation includes provisions that reauthorize the Prescription Drug User Fee Agreement (PDUFA) and the Medical Device User Fee and Modernization Act (MDUFMA) and promotes greater product safety. PDUFA has dramatically improved the drug approval process, remedying the significant “drug lag” of the 1990s. Likewise, MDUFMA offers similar streamlining of the approval process for medical devices. The Senate went on to approve similar legislation, H.R. 3580, which was signed into law by the president on September 27. into law by the president on September 27.
U.S. Chamber of Commerce 2007 House Scorecard position Aye +
U.S. Chamber of Commerce 2007 House Scorecard source Http:// house.htm +
U.S. Chamber of Commerce 2007 Senate Scorecard description The Chamber—a long-standing opponent of le The Chamber—a long-standing opponent of legislation to authorize the unregulated reimportation of medicines from foreign sources—supported a compromise amendment to S. 1082, the Food and Drug Administration Revitalization Act, that would require the Secretary of Health and Human Services to certify public health and safety before allowing any reimportation of pharmaceuticals into the United States. This compromise, which was approved 49-40, prevented an amendment from being included in S. 1082 that would have allowed unregulated drug reimportation. Reimported prescription drugs raise serious concerns about drug safety and counterfeiting. While the Chamber recognizes the need to make prescription drugs more accessible, reimportation legislation could eliminate the ability of drug manufacturers to ensure the integrity of their products and could expose Americans to mislabeled, tainted, or expired medications. No reimportation provisions were included in subsequent legislation that ultimately became law. nt legislation that ultimately became law.
U.S. Chamber of Commerce 2007 Senate Scorecard position Aye +
U.S. Chamber of Commerce 2007 Senate Scorecard source Http:// senate.htm +
Categories Stubs  + , Health Policy (U.S.)  + , U.S. legislation  + , Record votes  + , Congresspedia  +
hide properties that link here 
U.S. House of Representatives record vote 617, 110th Congress, Session 1 + , U.S. Senate record vote 151, 110th Congress, Session 1 + , U.S. prescription drug legislation + Bill of vote


Enter the name of the page to start browsing from.